Arrowstreet Capital’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227M | Buy |
429,012
+33,243
| +8% | +$15.3M | 0.1% | 186 |
|
|
2026
Q1 | $190M | Buy |
395,769
+20,736
| +6% | +$10.6M | 0.1% | 192 |
|
|
2025
Q4 | $211M | Buy |
375,033
+60,883
| +19% | +$34.6M | 0.12% | 171 |
|
|
2025
Q3 | $162M | Buy |
314,150
+211,411
| +206% | +$92.3M | 0.1% | 190 |
|
|
2025
Q2 | $32.2M | Buy |
102,739
+21,040
| +26% | +$6.32M | 0.02% | 542 |
|
|
2025
Q1 | $24.9M | Sell |
81,699
-20,262
| -20% | -$6.82M | 0.02% | 537 |
|
|
2024
Q4 | $33.9M | Sell |
101,961
-115,691
| -53% | -$39.2M | 0.03% | 470 |
|
|
2024
Q3 | $72.7M | Sell |
217,652
-19,697
| -8% | -$7.48M | 0.06% | 265 |
|
|
2024
Q2 | $97.8M | Sell |
237,349
-13,649
| -5% | -$5.41M | 0.09% | 198 |
|
|
2024
Q1 | $101M | Buy |
250,998
+56,899
| +29% | +$20M | 0.09% | 192 |
|
|
2023
Q4 | $59.5M | Buy |
194,099
+9,521
| +5% | +$2.57M | 0.06% | 238 |
|
|
2023
Q3 | $44.7M | Buy |
184,578
+36,207
| +24% | +$9.26M | 0.05% | 266 |
|
|
2023
Q2 | $35.6M | Buy |
148,371
+36,085
| +32% | +$7.5M | 0.04% | 302 |
|
|
2023
Q1 | $21.1M | Buy |
112,286
+9,638
| +9% | +$1.99M | 0.03% | 401 |
|
|
2022
Q4 | $21.8M | Buy |
102,648
+42,087
| +69% | +$8.41M | 0.03% | 376 |
|
|
2022
Q3 | $9.52M | Buy |
60,561
+18,852
| +45% | +$3.01M | 0.01% | 535 |
|
|
2022
Q2 | $6.24M | Buy |
41,709
+9,332
| +29% | +$1.35M | 0.01% | 566 |
|
|
2022
Q1 | $5.3M | Sell |
32,377
-166,481
| -84% | -$27.4M | 0.01% | 623 |
|
|
2021
Q4 | $43.3M | Sell |
198,858
-19,200
| -9% | -$4.02M | 0.05% | 312 |
|
|
2021
Q3 | $41.3M | Buy |
218,058
+35,159
| +19% | +$6.41M | 0.05% | 358 |
|
|
2021
Q2 | $32.3M | Buy |
182,899
+79,333
| +77% | +$13.7M | 0.04% | 441 |
|
|
2021
Q1 | $17M | Sell |
103,566
-89,733
| -46% | -$13.7M | 0.02% | 656 |
|
|
2020
Q4 | $26.9M | Sell |
193,299
-72,083
| -27% | -$9.09M | 0.04% | 493 |
|
|
2020
Q3 | $29.7M | Sell |
265,382
-22,261
| -8% | -$2.57M | 0.05% | 411 |
|
|
2020
Q2 | $26.8M | Sell |
287,643
-10,808
| -4% | -$920K | 0.05% | 386 |
|
|
2020
Q1 | $21.9M | Sell |
298,451
-41,313
| -12% | -$3.59M | 0.06% | 278 |
|
|
2019
Q4 | $28.6M | Buy |
339,764
+273,504
| +413% | +$21.2M | 0.07% | 300 |
|
|
2019
Q3 | $5.57M | Buy |
+66,260
| New | +$5.01M | 0.01% | 676 |
|
|
2019
Q1 | – | Sell |
-12,347
| Closed | -$654K | – | 1835 |
|
|
2018
Q4 | $654K | Sell |
12,347
-192,371
| -94% | -$10.6M | ﹤0.01% | 1048 |
|
|
2018
Q3 | $12.3M | Buy |
204,718
+127,264
| +164% | +$6.96M | 0.03% | 376 |
|
|
2018
Q2 | $3.33M | Buy |
77,454
+57,940
| +297% | +$2.34M | 0.01% | 608 |
|
|
2018
Q1 | $681K | Buy |
19,514
+5,733
| +42% | +$209K | ﹤0.01% | 920 |
|
|
2017
Q4 | $500K | Buy |
+13,781
| New | +$483K | ﹤0.01% | 1068 |
|
Other funds holding MEDP
WA
Arrowstreet Capital's MEDP Position: Q2 2026 in Review
Arrowstreet Capital increased its Medpace (MEDP) stake by 8.4% in Q2 2026, buying an estimated $15.3M and bringing the position to 429,012 shares worth $227M. The position accounts for 0.1% of the portfolio, ranked #186.
Arrowstreet Capital first reported a position in MEDP in Q4 2017 and has held it in 33 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Arrowstreet Capital held 429,012 shares of Medpace worth $227M as of Q2 2026.
- Arrowstreet Capital bought 33,243 Medpace shares in Q2 2026, an estimated $15.3M.
- Medpace made up 0.1% of Arrowstreet Capital's portfolio in Q2 2026, its #186 holding.
- Arrowstreet Capital first reported a position in Medpace in Q4 2017 and has held it in 33 quarters since.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.